Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112900 · ClinicalTrials.gov registry record · Phase 3
Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)
A Phase 3 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 3
- Development phase
- 7,122
- Enrollment target
NCT05112900 is a Phase 3 study that has completed, run by University of Utah. The registered enrollment target is 7,122 participants.
The verdict
NCT05112900, a Phase 3 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,122 participants
- Enrollment target
Study Summary
This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19) testing and existing infrastructure. The study team will work closely with schools and the Utah public health system to implement and test a shovel-ready and scalable health information technology approach that delivers automated text messages (TM) to students' parents around COVID-19 testing. In addition, some parents will receive a health navigator (HN) follow-up to ensure that tests are completed. Families will be offered the recently FDA-approved in-home serial testing approach if accessing in-person testing is a challenge. While this project is focused on COVID-19 testing, in the case that the COVID-19 vaccination becomes more relevant or is the priority of the school, the study team is able to tailor the intervention to focus on the vaccine as well. The outcomes in this study utilized parent/student reported data. Staff data were also collected but will not be reflected in primary outcome analyses.
Interventions
- BEHAVIORAL Text Messaging (TM)
- BEHAVIORAL Text Messaging + Health Navigation (TM+HN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,122 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05112900
The ClinicalTrials.gov registry entry for NCT05112900 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 7,122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Text Messaging (TM) is the first listed.
NCT05112900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05112900 about?
NCT05112900 is a clinical study titled "Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)". This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19) testing and existing infrastructure. The study team will work closely wit...
What is the current status of trial NCT05112900?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,122 participants. The study started on 2022-01-11. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT05112900?
The interventions under investigation include: Text Messaging (TM) (BEHAVIORAL), Text Messaging + Health Navigation (TM+HN) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05112900?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.